ANGPT2 and Hepatic fibrosis: In a subgroup analysis of patients with advanced fibrosis (F3/4) at baseline (Table 3), we further showed that a high Ang2 level at baseline is significantly associated with non-regression of liver fibrosis stage at 96 weeks after DAA completion.